Mitochondrial inhibitor atovaquone increases tumor oxygenation and inhibits hypoxic gene expression in patients with non-small cell lung cancer (Clinical Cancer Research, 2021)

(untitled) - Skwarski, M; McGowan, D; Belcher, E; Di Chiara, F; Stavroulias, D; McCole, M; Derham, J; Chu, K-Y; Teoh, E; Chauhan, J; O'reilly, D; Harris, B; et al.